Brain calcification due to secondary hyperparathyroidism in a child with chronic renal failure

Turkish Journal of Pediatrics

Volumn 47, Issue 3, 2005, Pages 287-290

  Bilge, Ilmay ^a   Sadikoǧlu, Banu ^a   Emre, Sevinç ^a   Şirin, Aydan ^a   Tatli, Burak ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Children; Dialysis; Metastatic calcification; Secondary hyperparathyroidism

Indexed keywords

CALCITONIN; CALCITRIOL; CALCIUM CARBONATE; PHENYTOIN; PHOSPHATE BINDING AGENT; VITAMIN D;

ADOLESCENT; ARTICLE; BLOOD VESSEL CALCIFICATION; BRAIN CALCIFICATION; CALCIUM HOMEOSTASIS; CASE REPORT; CHRONIC KIDNEY FAILURE; DISEASE CONTROL; DRUG USE; FACE MUSCLE; GAZE; HEMODIALYSIS PATIENT; HUMAN; LUNG CALCIFICATION; MALE; MUSCLE WEAKNESS; NEUROLOGIC DISEASE; PHOSPHATE METABOLISM; SECONDARY HYPERPARATHYROIDISM; SOFT TISSUE CALCIFICATION; SPEECH DISORDER;

ADOLESCENT; BRAIN DISEASES; CALCINOSIS; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; MAGNETIC RESONANCE IMAGING; MALE; RENAL DIALYSIS;

EID: 27544499995     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Block GA, Port FK. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis 2000; 35: 1226-1237.
2. Davies MR, Hruska KA. Pathophysiological mechanisms of vascular calcification in end stage renal disease. Kidney Int 2001; 60: 472-479.
3. Fletcher S, Gibson J, Brownjohn AM. Peritoneal calcification secondary to severe hyperparathyroidism. Nephrol Dial Transplant 1995; 10: 277-279.
4. Patten BM, Pages M. Severe neurological disease associated with hyperparathyroidism. Ann Neurol 1984; 15: 453-456.
5. Margolin D, Hammerstad D, Orwoll E, McClung M, Calhoun D. Intracranial calcification in hyperparathyroidism associated with gait apraxia and parkinsonism. Neurology 1980; 30: 1005-1007.
6. Ubara Y, Katori H, Tagami T, et al. Severe ectopic calcification of the intestinal wall in a patient on long term continuous ambulatory peritoneal dialysis therapy. Am J Kidney Dis 2000; 35: 761-766.
7. Grekas D, Balaskas E, Kampouris H, et al. Effective treatment of secondary hyperparathyroidism in hemodialysis patients by titration of intravenous calcitriol dosage. Clin Nephrol 1999; 52: 167-171.
8. Costa AF, Reis RM, Ribeiro MC, Moysés RMA, Jorgetti V. Effects of calcitriol on parathyroid function and on bone remodelling in secondary hyperparathyroidism. Nephrol Dial Transplant 2003; 18: 743-749.
9. Loghman-Adham M. Safety of new phosphate binders for chronic renal failure. Drug Saf 2003; 26: 1093-1115.
10. Yalcinkaya F, Ince E, Turner N, Ensari A, Ozkaya N. Spectrum of renal osteodystrophy in children on continuous ambulatory peritoneal dialysis. Pediatr Int 2000; 42: 53-57.
11. Cundy T, Hand DJ, Oliver DO, Woods CG, Wright FW, Kanis JA. Who gets renal bone disease before beginning dialysis? Br Med J (Clin Res Ed) 1985; 26: 271-275.
12. Kleeman CR. The role of chronic anion gap and/or nonanion gap acidosis in the osteodystrophy of chronic renal failure in the predialysis era: a minority report. Miner Electrolyte Metab 1994; 20: 81-96.